C9orf72-associated FTD/ALS: when less is more
- PMID: 24139028
- PMCID: PMC4982762
- DOI: 10.1016/j.neuron.2013.10.010
C9orf72-associated FTD/ALS: when less is more
Abstract
Hexanucleotide repeat expansions in C9ORF72 cause neurodegeneration in FTD and ALS by unknown mechanisms. A new report, by Donnelly et al. (2013), finds that these repeats trigger a pathogenic gain-of-function cascade that can be corrected by suppressing expression of the repeat transcript, paving the way for therapeutic strategies aimed at eliminating the toxic RNA.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment on
-
RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.Neuron. 2013 Oct 16;80(2):415-28. doi: 10.1016/j.neuron.2013.10.015. Neuron. 2013. PMID: 24139042 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous